newsfilter
← Latest News
Business Wire·

Deciphera Pharmaceuticals Announces Eight Presentations Highlighting Discovery Research Programs at the American Association for Cancer Research (AACR) Annual Meeting 2023

– First Preclinical Data for Pan-RAF Inhibitor DCC-3084 to be Presented; IND Filing Expected in Second Half of 2023 – – New Preclinical Data Supports ULK inhibitor DCC-3116 in Combination with QINLOCK® in GIST and